Cancer Research

Published by: American Association for Cancer Research  

People

  1. De Stanchina
    De Stanchina
  2. Rosen
    Rosen
  3. Chandarlapaty
    Chandarlapaty
  4. Berger
    Berger
  5. Boyer
    Boyer
  6. Mukherjee
    Mukherjee
  7. Yaeger
    Yaeger
  8. Drilon
    Drilon
  9. Kulick
    Kulick
  10. Lito
    Lito

Groups

  1. Breast Medicine Service (14)
  2. Department of Medicine (14)
  3. GSK Faculty (14)
  4. Solid Tumor Oncology Division (14)
  5. Human Oncology and Pathogenesis Program (12)
  6. Sloan Kettering Institute Faculty (12)
  7. Molecular Pharmacology and Chemistry Program Faculty (11)
  8. Sloan Kettering Institute Postdocs (10)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  10. MSK Grad Students (6)
Search Within
  1. "Breast Medicine Service"
  2. "Elisa De Stanchina"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (1)
Groups
  1. Breast Medicine Service (14)
  2. Department of Medicine (14)
  3. GSK Faculty (14)
  4. Solid Tumor Oncology Division (14)
  5. Human Oncology and Pathogenesis Program (12)
  6. Sloan Kettering Institute Faculty (12)

More Groups

People
  1. Elisa De Stanchina (14)
  2. Neal Rosen (11)
  3. Sarat Chandarlapaty (7)
  4. Michael Berger (5)
  5. Jose Baselga (4)
  6. Christine Pratilas (3)

More People

Years
  1. 2022 (3)
  2. 2020 (2)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2014 (2)

More Years

Publishers
  1. American Association for Cancer Research (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Boyer, J. A.; Qiu, J.; Chen, X.; de Stanchina, E.; Chandarlapaty, S.; Levchenko, A.; Rosen, N.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Optimization of intermittent high dose lapatinib administration with or without capecitabine: A rational approach to drug dosing and scheduling using Norton-Simon modeling
    Meeting Abstract

    Morikawa, A.; De Stanchina, E.; Patil, S.; Chandarlapaty, S.; Li, B. T.; Norton, L.; Seidman, A. D.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
    Meeting Abstract

    Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Yao, Z.; Mukherjee, R.; Cai, L.; Barratt, D.; Ward, R.; Klinowska, T.; Destanchina, E.; Berger, M.; Baselga, J.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research